Home/S4 Medical/Ron Farnham
RF

Ron Farnham

VP of Business Development

S4 Medical

Therapeutic Areas

S4 Medical Pipeline

DrugIndicationPhase
esolutionEsophageal protection during atrial fibrillation ablationApproved